These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


76 related items for PubMed ID: 10414876

  • 1. Abnormal lipids and the acquired immunodeficiency syndrome: is there a problem and what should we do about it?
    Crook MA, Mir N.
    Int J STD AIDS; 1999 Jun; 10(6):353-6. PubMed ID: 10414876
    [Abstract] [Full Text] [Related]

  • 2. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
    Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR.
    J Clin Endocrinol Metab; 1992 May; 74(5):1045-52. PubMed ID: 1373735
    [Abstract] [Full Text] [Related]

  • 3. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA.
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [Abstract] [Full Text] [Related]

  • 4. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R, Borggreve SE, Dullaart RP.
    Clin Lab; 2003 Jan; 49(11-12):601-13. PubMed ID: 14651331
    [Abstract] [Full Text] [Related]

  • 5. Metabolic abnormalities: triglyceride and low-density lipoprotein.
    Krauss RM, Siri PW.
    Endocrinol Metab Clin North Am; 2004 Jun; 33(2):405-15. PubMed ID: 15158526
    [Abstract] [Full Text] [Related]

  • 6. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P, Kannan NK.
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [Abstract] [Full Text] [Related]

  • 7. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P.
    Circulation; 2003 Apr 01; 107(12):1640-6. PubMed ID: 12668499
    [Abstract] [Full Text] [Related]

  • 8. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T, Hanefeld M.
    Exp Clin Endocrinol Diabetes; 2004 Feb 01; 112(2):75-9. PubMed ID: 15031770
    [Abstract] [Full Text] [Related]

  • 9. [Lipids and AIDS].
    Ducobu J, Payen MC.
    Rev Med Brux; 2000 Feb 01; 21(1):11-7. PubMed ID: 10748683
    [Abstract] [Full Text] [Related]

  • 10. Alterations in serum levels of lipids and lipoproteins with indinavir therapy for human immunodeficiency virus-infected patients.
    Roberts AD, Muesing RA, Parenti DM, Hsia J, Wasserman AG, Simon GL.
    Clin Infect Dis; 1999 Aug 01; 29(2):441-3. PubMed ID: 10476757
    [Abstract] [Full Text] [Related]

  • 11. The Lipoprotein Profile in HIV Infected Patients.
    Spósito AC, Caramelli B, Sartori AM, F Ramires JA.
    Braz J Infect Dis; 1997 Dec 01; 1(6):275-283. PubMed ID: 11105149
    [Abstract] [Full Text] [Related]

  • 12. Statins and diabetes.
    Carmena R, Betteridge DJ.
    Semin Vasc Med; 2004 Nov 01; 4(4):321-32. PubMed ID: 15861314
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Postprandial hyperlipidemia, small and dense LDL, HDL sub-fractions].
    Braschi S.
    Ann Med Interne (Paris); 2001 Apr 01; 152(3):162-8. PubMed ID: 11431575
    [Abstract] [Full Text] [Related]

  • 15. Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus.
    Ding SY, Tigno XT, Hansen BC.
    Metabolism; 2007 Jun 01; 56(6):838-46. PubMed ID: 17512318
    [Abstract] [Full Text] [Related]

  • 16. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G, De Natale C, Iovine C, Patti L, Di Marino L, Coppola S, Del Prato S, Riccardi G, Rivellese AA.
    Arterioscler Thromb Vasc Biol; 2004 Dec 01; 24(12):2397-402. PubMed ID: 15458975
    [Abstract] [Full Text] [Related]

  • 17. Lipid evaluation in HIV-1-positive patients treated with protease inhibitors.
    Schmidt HH, Behrens G, Genschel J, Stoll M, Dejam A, Haas R, Manns MP, Schmidt RE.
    Antivir Ther; 1999 Dec 01; 4(3):163-70. PubMed ID: 12731756
    [Abstract] [Full Text] [Related]

  • 18. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R.
    Metabolism; 2003 Jan 01; 52(1):116-21. PubMed ID: 12524671
    [Abstract] [Full Text] [Related]

  • 19. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
    Adiels M, Olofsson SO, Taskinen MR, Borén J.
    Arterioscler Thromb Vasc Biol; 2008 Jul 01; 28(7):1225-36. PubMed ID: 18565848
    [Abstract] [Full Text] [Related]

  • 20. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T, Hirano T, Yamamoto T, Ito Y, Adachi M.
    Metabolism; 2006 Jul 01; 55(7):879-84. PubMed ID: 16784958
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.